Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Footnotes
  • References
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Retraction Free access | 10.1172/JCI87345

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

Rosa Marina Melillo, Maria Domenica Castellone, Valentina Guarino, Valentina De Falco, Anna Maria Cirafici, Giuliana Salvatore, Fiorina Caiazzo, Fulvio Basolo, Riccardo Giannini, Mogens Kruhoffer, Torben Orntoft, Alfredo Fusco, and Massimo Santoro

Find articles by Melillo, R. in: JCI | PubMed | Google Scholar

Find articles by Castellone, M. in: JCI | PubMed | Google Scholar

Find articles by Guarino, V. in: JCI | PubMed | Google Scholar

Find articles by De Falco, V. in: JCI | PubMed | Google Scholar

Find articles by Cirafici, A. in: JCI | PubMed | Google Scholar

Find articles by Salvatore, G. in: JCI | PubMed | Google Scholar

Find articles by Caiazzo, F. in: JCI | PubMed | Google Scholar

Find articles by Basolo, F. in: JCI | PubMed | Google Scholar

Find articles by Giannini, R. in: JCI | PubMed | Google Scholar

Find articles by Kruhoffer, M. in: JCI | PubMed | Google Scholar

Find articles by Orntoft, T. in: JCI | PubMed | Google Scholar

Find articles by Fusco, A. in: JCI | PubMed | Google Scholar

Find articles by Santoro, M. in: JCI | PubMed | Google Scholar

Published April 1, 2016 - More info

Published in Volume 126, Issue 4 on April 1, 2016
J Clin Invest. 2016;126(4):1603–1603. https://doi.org/10.1172/JCI87345.
Copyright © 2016, American Society for Clinical Investigation
Published April 1, 2016 - Version history
View PDF

Related article:

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells
Rosa Marina Melillo, … , Alfredo Fusco, Massimo Santoro
Rosa Marina Melillo, … , Alfredo Fusco, Massimo Santoro
Retraction

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

  • Text
  • PDF
Abstract

Authors

Rosa Marina Melillo, Maria Domenica Castellone, Valentina Guarino, Valentina De Falco, Anna Maria Cirafici, Giuliana Salvatore, Fiorina Caiazzo, Fulvio Basolo, Riccardo Giannini, Mogens Kruhoffer, Torben Orntoft, Alfredo Fusco, Massimo Santoro

×

Original citation: J Clin Invest. 2005;115(4):1068–1081. doi:10.1172/JCI22758.

Citation for this retraction: J Clin Invest. 2016;126(4):1603. doi:10.1172/JCI87345.

At the request of the corresponding author, the JCI is retracting this manuscript. The corresponding author recently notified the JCI that multiple microscopy images in Figure 2B were previously published and were used to represent different samples in another publication by the corresponding author’s group (1). The authors have stated that experimental data produced ad hoc are consistent with those in the original publication; however, the paper is being retracted due to data duplication and misrepresentation in the original publication.

Footnotes

See the related article beginning on page 1068.

References
  1. Melillo RM, et al. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. Am J Pathol. 2004;165(2):511–521.
    View this article via: PubMed CrossRef Google Scholar
Version history
  • Version 1 (April 1, 2016): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • References
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts